GlassScriptPhysician profile
Kabir Mody
NPI 1902096860
$51,562.86
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $26K · 2021: $5,771 · 2024: $46.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $46.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $46.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $26,948.64 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $7,323.60 | 2019-2021 | |
| Exelixis INC. | $6,681.02 | 2019 | |
| Genentech USA, INC. | $5,523.34 | 2019-2020 | |
| Biocompatibles, INC. | $2,480.00 | 2019 | |
| Boston Scientific Corporation | $2,116.90 | 2021 | |
| Astrazeneca Ab | $188.05 | 2020 | |
| Novocure INC. | $138.21 | 2021 | |
| Amgen INC. | $91.33 | 2021 | |
| Merck Sharp & Dohme LLC | $46.17 | 2024 | |
| Celgene Corporation | $25.60 | 2019 |
8 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kabir Mody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.